Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

JAMA: CABG rates decline in U.S., while PCI remains steady

Researchers from the University of Pennsylvania School of Medicine in Philadelphia found a substantial decrease in CABG surgery utilization rates, but PCI utilization rates remained unchanged in U.S. hospitals between 2001 and 2008, according to a serial cross-sectional study published in the May 3 edition of the Journal of the American Medical Association.

Healthcare IT market in emerging economies to double by 2015

Research and Markets has published Healthcare IT Market in Emerging Economies (2010-2015), which cites the growth of medical tourism, demand for better quality healthcare delivery by a growing aging population and an increase in the chronic disease patient population as driving the increased adoption of IT in emerging markets.

AJR: CT suffices for determining NSCLC tumor volume

Although PET and CT both offered concordance with histologic measurements of non-small-cell lung cancer (NSCLC), CT is often accurate for staging primary T1 and T2 NSCLC, according to a study published in this month's American Journal of Roentgenology.

FDA clears Sectras full-field digital mammo system

The FDA has granted approval for the 510(k) application by Sectra Medical Systems to sell the Sectra MicroDose L30 full-field digital mammography (FFDM) unit in the U.S.

Radiology: ASIR slashes CT rad dose

Image reconstruction can dramatically reduce the required electrical current and drop chest CT-induced radiation to as low as 3.5 mGy while maintaining acceptable image quality, according to a study published in the May issue of Radiology.

ARRS: The upside of capitation

CHICAGOIts possible to survive and thrive under capitation, opined Fred Gaschen, MBA, with Radiological Associates of Sacramento in Calif., during a Monday presentation at the annual meeting of the American Roentgen Ray Society (ARRS).

FDA tackles device reprocessing

The Food and Drug Administration (FDA) will hold a public workshop to discuss its recent findings concerning the quality of reprocessing of reusable medical devices.

New ASTRO lung cancer guidelines reject RT + chemo

As part of an effort to clarify variable radiotherapy (RT) and chemotherapy treatment regimens, the American Society for Radiation Oncology (ASTRO) has published a series of guidelines for lung cancer treatment, notably concluding that the literature does not support chemotherapy treatment concurrent with palliative RT.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.